Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools ; year:2021
Advanced science ; (2021)
- Urheber
- DOI
-
10.1002/advs.202002499
- URN
-
urn:nbn:de:101:1-2021030412143050800418
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jahromi, Leila Pourtalebi
- Shahbazi, Mohammad‐Ali
- Maleki, Aziz
- Azadi, Amir
- Santos, Hélder A.
Ähnliche Objekte (12)
Biomimetic cell-derived nanocarriers in cancer research
Xenogeneic Serum‐Free Human Cell‐Derived Tissue Engineered Matrices for the Development of Clinical‐Grade Biomimetic Cardiovascular Devices
Large magnetic anisotropy in chemically engineered iridium dimer
Boosting antitumor drug efficacy with chemically engineered multidomain proteins
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract
Chemically Engineered GaN Thin Films for Light‐Stimulated Artificial Synapses
Therapeutic Potential of Engineered Extracellular Vesicles
A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis
Biomimetic cell-derived nanocarriers in cancer research
Xenogeneic Serum‐Free Human Cell‐Derived Tissue Engineered Matrices for the Development of Clinical‐Grade Biomimetic Cardiovascular Devices
Large magnetic anisotropy in chemically engineered iridium dimer
Boosting antitumor drug efficacy with chemically engineered multidomain proteins
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract
Chemically Engineered GaN Thin Films for Light‐Stimulated Artificial Synapses
Therapeutic Potential of Engineered Extracellular Vesicles
A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis
Biomimetic cell-derived nanocarriers in cancer research
Xenogeneic Serum‐Free Human Cell‐Derived Tissue Engineered Matrices for the Development of Clinical‐Grade Biomimetic Cardiovascular Devices
Large magnetic anisotropy in chemically engineered iridium dimer
Boosting antitumor drug efficacy with chemically engineered multidomain proteins
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Development of a Chemically Driven Biomimetic Modular Artificial Muscle (BiMAM)
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract
Chemically Engineered GaN Thin Films for Light‐Stimulated Artificial Synapses
Therapeutic Potential of Engineered Extracellular Vesicles